NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Adocia SA (PA: ADOC)
ADOC Technical Analysis
5
As on 1st Apr 2025 ADOC STOCK Price closed @ 4.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 8.29 & Strong Sell for SHORT-TERM with Stoploss of 8.89 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADOCSTOCK Price
Open | 3.92 | Change | Price | % |
High | 4.16 | 1 Day | 0.05 | 1.27 |
Low | 3.85 | 1 Week | -0.46 | -10.31 |
Close | 4.00 | 1 Month | -0.66 | -14.16 |
Volume | 143304 | 1 Year | -3.06 | -43.34 |
52 Week High 12.12 | 52 Week Low 3.80 |
PA France Most Active Stocks
ALEUP | 0.01 | -50.00% |
FTI | 5.91 | -1.66% |
VIEDS | 0.72 | 4.35% |
ORA | 12.09 | 0.83% |
ALNRG | 0.01 | % |
ENGI | 18.17 | 0.72% |
CGG | 0.69 | -2.82% |
ACA | 17.01 | 1.43% |
ALHYG | 0.01 | 0.00% |
CS | 40.00 | 1.52% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
ADOC Daily Charts |
ADOC Intraday Charts |
Whats New @ Bazaartrend |
ADOC Free Analysis |
|
ADOC Important Levels Intraday
RESISTANCE | 4.60 |
RESISTANCE | 4.41 |
RESISTANCE | 4.29 |
RESISTANCE | 4.17 |
SUPPORT | 3.83 |
SUPPORT | 3.71 |
SUPPORT | 3.59 |
SUPPORT | 3.40 |
ADOC Forecast April 2025
4th UP Forecast | 9.76 |
3rd UP Forecast | 7.91 |
2nd UP Forecast | 6.77 |
1st UP Forecast | 5.63 |
1st DOWN Forecast | 2.37 |
2nd DOWN Forecast | 1.23 |
3rd DOWN Forecast | 0.09 |
4th DOWN Forecast | -1.76 |
ADOC Weekly Forecast
4th UP Forecast | 7.33 |
3rd UP Forecast | 6.26 |
2nd UP Forecast | 5.60 |
1st UP Forecast | 4.94 |
1st DOWN Forecast | 3.06 |
2nd DOWN Forecast | 2.40 |
3rd DOWN Forecast | 1.74 |
4th DOWN Forecast | 0.67 |
ADOC Forecast2025
4th UP Forecast | 21.19 |
3rd UP Forecast | 15.68 |
2nd UP Forecast | 12.27 |
1st UP Forecast | 8.86 |
1st DOWN Forecast | -0.86 |
2nd DOWN Forecast | -4.27 |
3rd DOWN Forecast | -7.68 |
4th DOWN Forecast | -13.19 |
Adocia SA ( PA France Symbol : ADOC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADOC Other Details
Segment | EQ | |
Market Capital | 64342592.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ADOC Address
![]() |
ADOC Latest News
ADOC Business Profile
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The company's proprietary BioChaperone technological platform is designed and developed to enhance the effectiveness and/or safety of therapeutic proteins. Its clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insulin analog lispro; BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro; and BioChaperone Pramlintide Insulin, a prandial combination of human insulin with amylin pramlintide M1Pram. The company's clinical pipeline also includes BioChaperone Glucagon, which is an aqueous formulation of human glucagon for the treatment of hypoglycemia. Its preclinical pipeline includes BioChaperone LisPram), which is a combination of rapid human insulin analogues and Pramlintide; BioChaperone Glargine GLP1 that is a combination of insulin glargine with GLP-1 receptor agonists for the treatment of diabetes; and BioChaperone Glucagon GLP1, which is a combination of glucagon and a GLP-1 receptor agonist for the treatment of obesity. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was founded in 2005 and is headquartered in Lyon, France. Address: 115 Avenue Lacassagne, Lyon, France, 69003
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service